The National Institutes of Health has awarded ValVention Inc. $350,000 to study the effectiveness of FoldaValve™ transcatheter aortic valve replacement (TAVR) system. The NIH funding will support a project to test the hypothesis that the patented sheathed inverse folding mechanism of the FoldaValve™ technology is more durable and protective of the valve’s structural integrity when compared with standard crimping methods…
